H. R. 5341
IN THE HOUSE OF REPRESENTATIVES
May 7, 2012
Mrs. Capps introduced the following bill; which was referred to the Committee on Energy and Commerce
To improve postmarket risk identification and analysis with respect to devices, and for other purposes.
This Act may be cited as the
Sentinel Assurance for Effective
Devices Act of 2012.
Inclusion of devices in postmarket risk identification and analysis system; unique device identification system
Inclusion of devices in postmarket risk identification and analysis system
Section 522 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360l) is amended by adding at the end the following:
Inclusion of devices in the postmarket risk identification and analysis system
Except as provided in paragraph (2), the Secretary shall amend the procedures established and maintained under section 505(k)(3)(C) in order to expand the postmarket risk identification and analysis system established under such section to include and apply to devices.
In carrying out this subsection:
The Secretary shall not apply the procedures of section 505(k)(3)(C)(i)(II) to devices.
Section 505(k)(3)(C)(i)(III)(bb) is deemed to refer to private sector health-related electronic data (such as medical device utilization data, health insurance claims data, and procedure and device registries).
Section 505(k)(3)(C)(iv)(II) is deemed to refer to the Data Extraction and Longitudinal Time Analysis system instead of the Vaccine Safety Datalink.
In carrying out this subsection, the Secretary shall give priority to postmarket risk identification and analysis with respect to class II and class III devices.
To help ensure effective implementation of the system described in paragraph (1) with respect to devices, the Secretary shall engage outside stakeholders in development of the system, and gather information from outside stakeholders regarding the content of an effective sentinel program, through a public hearing, advisory committee meeting, maintenance of a public docket, or other similar public measures.
In carrying out this subsection, the Secretary shall use data with respect to devices cleared under section 510(k) or approved under section 515, which may include claims data, patient survey data, standardized analytic files that allow for the pooling and analysis of data from disparate data environments, and any other data deemed appropriate by the Secretary.
Chapter 35 of title 44, United States Code, shall not apply to the collection of voluntary information from health care providers, such as voluntary surveys or questionnaires, initiated by the Secretary for purposes of postmarket risk identification for devices.
Unique Device Identification System
Section 519(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360i(f)) is amended—
The Secretary shall promulgate and inserting
than December 31, 2012, the Secretary shall issue final; and
by adding at the end the following:
The Secretary shall implement the unique device identification system
under this subsection for class III devices not later than 1 year after the
date on which the final regulations are issued, for implantable,
life-sustaining, and life-supporting devices not later than 3 years after such
date, and for all other devices not later than 5 years after such